Real-time enrollment status for this acquired immunodeficiency syndrome clinical trial
Current Status
Recruiting
Checked: September 7, 2026 at 9:31 AM UTC
| NCT Number | NCT02479698 |
| Recruiting Status | Recruiting |
| Condition | Acquired Immunodeficiency Syndrome |
| Phase | PHASE2 |
| Target Enrollment | 100 participants |
| Active Locations | 1 sites in the US |
| Sponsor | M.D. Anderson Cancer Center |
| Last Updated on CT.gov | September 4, 2026 (3 days ago) |
As of September 7, 2026: Clinical trial NCT02479698 is currently recruiting participants. This phase2 study for acquired immunodeficiency syndrome is actively seeking new participants at 1 location across the United States. The study is sponsored by M.D. Anderson Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT02479698 is actively recruiting participants as of September 7, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT02479698 was last updated 3 days ago (September 4, 2026). HelloStudys verifies this status automatically.